Emerald Advisers, LLC Wave Life Sciences Ltd. Transaction History
Emerald Advisers, LLC
- $2.35 Billion
- Q4 2024
A detailed history of Emerald Advisers, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Emerald Advisers, LLC holds 3,162,369 shares of WVE stock, worth $32.1 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
3,162,369
Previous 2,881,510
9.75%
Holding current value
$32.1 Million
Previous $23.6 Million
65.56%
% of portfolio
1.66%
Previous 0.98%
Shares
3 transactions
Others Institutions Holding WVE
# of Institutions
174Shares Held
118MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$185 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$102 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$98.6 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$68.5 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$62.6 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $882M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...